Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Reducing the dose of Eli Lilly’s obesity shot Zepbound could provide a safe, effective and potentially cheaper option for the maintenance of weight loss, according to new data. The findings come from a trial called ...
May 12, 2026 06:01 PM EDT PharmaGLP-1 drugs Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options Elizabeth Cairns Senior biopharma journalist Reducing the dose of Eli Lilly’s obesity shot Zepbound could provide a safe, effective and potentially cheaper option for the maintenance of weight loss, according … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that